Numerous studies have demonstrated that the formation and progression of certain malignancies, including bladder cancer, astroglioma, hepatocellular carcinoma, and colorectal cancer, are typically associated with the aberrant regulation of the PPAR signaling pathway (36–39). Here, PPARA is linked to urinary bladder carcinoma.